The diagnostic accuracy of PSMA-PET/CT in predicting pathological upgrading after radical prostatectomy in patients with prostate cancer is moderate; however, despite its imperfections, this method demonstrates significant potential for application and warrants further research in related fields. Here, FOLH1 is linked to prostate cancer.